Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
5
×
seattle top stories
texas blog main
texas top stories
5
×
wisconsin blog main
5
×
wisconsin top stories
national
eli lilly
amgen
calcitonin gene-related peptide
cancer
drugs
eptinezumab
erenumab
fremanezumab
galcanezumab
medical device
migraine research foundation
What
drug
5
×
fda
5
×
approval
won
approved
class
companies
developed
migraine
new
oral
agency
aimmune
allergy
amgen
arguments
awarded
big
bio
cancer
candidates
commercialized
competitors
decades
digital
disease
drugs
eisai
epidemic
fatty
flags
frenzied
friday
gets
growing
head
higher
immunotherapy
incidence
known
Language
unset
Current search:
drug
×
biotech
×
" texas top stories "
×
" seattle blog main "
×
fda
×
" wisconsin blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines